​

Vivos Therapeutics Ownership | Who Owns Vivos Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Vivos Therapeutics Ownership Summary

Vivos Therapeutics is owned by 4.67% institutional investors, 29.53% insiders, and 65.80% retail investors. Commonwealth equity services is the largest institutional shareholder, holding 0.45% of VVOS shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.03% of its assets in Vivos Therapeutics shares.

VVOS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVivos Therapeutics4.67%29.53%65.80%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryMedical Device Stocks52.25%10.55%37.19%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Commonwealth equity services41.00K0.45%$127.00K
Xtx topco20.53K0.24%$64.87K
Signaturefd547.000.01%$1.70K
Ronald blue trust160.000.00%$496.00
Raymond james financial74.000.00%$234.00
Kozak & associates49.000.00%$294.00
Global retirement partners23.000.00%$71.00
Envestnet asset management---
Group one trading---
Anson funds management lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Xtx topco20.53K0.00%$64.87K
Commonwealth equity services41.00K0.00%$127.00K
Kozak & associates49.000.00%$294.00
Envestnet asset management---
Ronald blue trust160.00-$496.00
Group one trading---
Anson funds management lp---
Advisor group---
Global retirement partners23.00-$71.00
Signaturefd547.00-$1.70K

Top Buyers

HolderShares% AssetsChange
Xtx topco20.53K0.00%20.53K
Raymond james financial74.00-74.00
Commonwealth equity services41.00K0.00%-
Ronald blue trust160.00--
Kozak & associates49.000.00%-

Top Sellers

HolderShares% AssetsChange
Anson funds management lp---242.58K
Envestnet asset management---38.87K
Ewa---10.46K
Group one trading---228.00
Advisor group---200.00

New Positions

HolderShares% AssetsChangeValue
Xtx topco20.53K0.00%20.53K$64.87K
Raymond james financial74.00-74.00$234.00

Sold Out

HolderChange
Advisor group-200.00
Group one trading-228.00
Ewa-10.46K
Envestnet asset management-38.87K
Anson funds management lp-242.58K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202517-15.00%401,289-23.45%412.55%9-25.00%1-
Mar 31, 2025205.26%524,22012.11%69.68%12100.00%1-
Dec 31, 202419-13.64%467,59390.82%757.86%6-45.45%1-50.00%
Sep 30, 20242222.22%245,04831.11%311.05%1122.22%2100.00%
Jun 30, 20241820.00%186,89637.05%516.58%980.00%1-50.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr60.63K1.03%18.00K
Fidelity Extended Market Index32.44K0.43%-267.00
Fidelity Total Market Index12.14K0.16%6.32K
Fidelity Series Total Market Index9.07K0.12%-
NT Ext Equity Mkt Idx Fd - NL6.80K0.12%-
Spartan Extended Market Index Pool E6.21K0.11%242.00
NT Ext Equity Mkt Idx Fd - L5.63K0.10%-
Northern Trust Extended Eq Market Idx5.63K0.10%-
Spartan Extended Market Index Pool F6.86K0.09%267.00
NT Ext Equity Mkt Idx Fd - DC - NL - T25.28K0.09%-13.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 20, 2023Huntsman Ronald Kirk Chief Executive OfficerBuy$7.42K
Jun 16, 2023Huntsman Ronald Kirk Chief Executive OfficerBuy$5.40K
Jun 16, 2023Huntsman Ronald Kirk Chief Executive OfficerBuy$2.65K
Jun 15, 2023Huntsman Ronald Kirk Chief Executive OfficerBuy$10.50
Jun 14, 2023Huntsman Ronald Kirk Chief Executive OfficerBuy$4.90K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q2--
2023 Q25-
2022 Q41-
2022 Q21-

VVOS Ownership FAQ

Who Owns Vivos Therapeutics?

Vivos Therapeutics shareholders are primarily institutional investors at 4.67%, followed by 29.53% insiders and 65.80% retail investors. The average institutional ownership in Vivos Therapeutics's industry, Medical Device Stocks, is 52.25%, which Vivos Therapeutics falls below.

Who owns the most shares of Vivos Therapeutics?

Vivos Therapeutics’s largest shareholders are Commonwealth equity services (41K shares, 0.45%), Xtx topco (20.53K shares, 0.24%), and Signaturefd (547 shares, 0.01%). Together, they hold 0.70% of Vivos Therapeutics’s total shares outstanding.

Does Blackrock own Vivos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Vivos Therapeutics.

Who is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested?

Xtx topco is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 20.53K Vivos Therapeutics shares, valued at 64.87K$.

Who is the top mutual fund holder of Vivos Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Vivos Therapeutics shares, with 1.03% of its total shares outstanding invested in 60.63K Vivos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools